<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01849185</url>
  </required_header>
  <id_info>
    <org_study_id>mmc120213ctil</org_study_id>
    <nct_id>NCT01849185</nct_id>
  </id_info>
  <brief_title>Probiotic BIO-25 as a Supplement to Statins for the Treatment of Hypercholesterolemia</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to examine whether probiotics given to hypercholesterolemic patients
      treated with statins, would further decrease LDL-Cholesterol levels.

      The secondary objective is to examine whether adding of probiotics to statins would decrease
      fasting glucose levels and glycolysated hemoglobin
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>LDL-Cholesterol levels.</measure>
    <time_frame>8 weeks</time_frame>
    <description>The primary objective is to examine whether probiotics given to hypercholesterolemic patients treated with statins, would further decrease LDL-Cholesterol levels.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1C</measure>
    <time_frame>8 weeks</time_frame>
    <description>The secondary objective is to examine whether adding of probiotics to statins would decrease fasting glucose levels and glycosylated hemoglobin</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>BIO 25 (food supplements)twice a day for 8 weeks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>BIO 25 - Innovative Formula contains 11 different strains of probiotic bacteria patents and more than 25 billion active bacteria in each capsule.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo twice a day for 8 weeks</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo twice a day for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Food supplement</intervention_name>
    <arm_group_label>BIO 25 (food supplements)twice a day for 8 weeks</arm_group_label>
    <arm_group_label>Placebo twice a day for 8 weeks</arm_group_label>
    <other_name>BIO-25</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1) Patients on maximal tolerated dose of conventional statins treated for at least eight
        weeks on simvastatin 40, pravastatin 40, atorvastatin 40-80 or rosuvastatin 20-40 mg, who
        failed to achieve target values of LDL-cholesterol according to the European Socety
        Cardiology guidelines 2012.

        Exclusion Criteria:

          1. Patients on chronic antibiotic treatment

          2. Patients with immune disorders

          3. Patients who are not receiving maximal dose of statin therapy or receive combination
             of statins for dyslipidemia.

          4. Patients who experienced myocardial infarction within less than two months.

          5. Patients who consume probiotics.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tatiana Berlin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Cardiology Meir MC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Morris Mosseri, MD</last_name>
    <phone>97297472587</phone>
    <email>morris.mosseri@clalit.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tatiana Berlin, MD</last_name>
    <phone>97297472587</phone>
    <email>tatiana.berlin@clalit.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of Cardiology Meir MC</name>
      <address>
        <city>Kfar Saba</city>
        <zip>44281</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2013</study_first_submitted>
  <study_first_submitted_qc>May 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2013</study_first_posted>
  <last_update_submitted>May 7, 2013</last_update_submitted>
  <last_update_submitted_qc>May 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypercholesterolemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

